CleveMed announces the release of IDcheck to verify the identity of patients during home sleep studies with SleepView. Home sleep testing with IDcheck meets the requirements of many department of transportation guidelines while providing patients with a lower cost alternative to fulfill required testing. The diagnosis and treatment of sleep apnea is vital for preventing daytime sleepiness in drivers, which is a leading factor in auto accidents.
An estimated 40 million people in the US alone are affected by a sleep disorder, many of whom are undiagnosed. About 30 million Americans have undiagnosed Sleep Apnea. Sleep Apnea is the intermittent failure to breathe while you sleep. Obstructive Sleep Apnea (OSA) is the most common type of Apnea. In this form of the disease, the airway collapses, cutting off air flow to the lungs. As Obstructive Sleep Apnea progresses, it has a cumulative effect. This means that the longer the disease goes untreated, the greater the negative side effects and associated health risks. If sleep apnea remains untreated, other health conditions may emerge or current health problems may worsen, including: high blood pressure, heart disease, stroke and diabetes.
“IDcheck is worn discreetly under the patient’s shirt, allowing the patient to fully participate in activities during the day,” said Sarah Weimer, director of sleep products, “this is important for patient acceptance and makes the home sleep test very convenient.”
